+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Spatial Genomics & Transcriptomics Market by Product (Consumables, Instruments, Software), Technology (Immunohistochemistry Screening, Spatial Genomics, Spatial Transcriptomics), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5788853
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Spatial Genomics & Transcriptomics Market size was estimated at USD 782.33 million in 2023, USD 879.03 million in 2024, and is expected to grow at a CAGR of 13.62% to reach USD 1,913.12 million by 2030.

Spatial genomics & transcriptomics is a technique that allows users to obtain gene expression information in a spatial context. This technique has become vital for biomedical research, particularly in developmental biology, cancer, immunology, and neuroscience, to design more effective therapeutics. The rising popularity of spatial analysis in precision medicine has also brought the regulatory and ethical acceptance of genomics and sequencing technologies. However, limited awareness of genomic medicine in developing economies and a shortage of trained medical professionals limit the expansion of spatial techniques. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing are also restraining factors for the market development. Technological advancements in spatial biology primarily focused on artificial intelligence (AI), 3D printing, and standardized diagnostic biomarkers have emerged as a boon for fighting these challenges for the use of spatial genomics and transcriptomics. In the coming years, rising public and private funding for genomics & transcriptomics research is also expected to diversify the use of these technologies in healthcare and life science.

Regional Insights

The Americas has a strong and growing spatial genomics and transcriptomics market, driven by the presence of well-recognized healthcare startups and immense investments for diversifying the product’s R&D portfolio. In October 2022, the Government of Canada announced an investment of over USD 5.6 million for Ontario Genomics to deliver the BioCreate program for helping genomics SMEs in the health, food, and agriculture, and cleantech sectors to bring new products and technologies to market. In the Asia-Pacific region, spatial analysis is used in regenerative medicine drug development scenarios funded by government and biopharma companies. The country’s increased disease burden has been the pillar for the increasing shift to advanced technologies such as spatial genomics and transcriptomics. Owing to the increased concerns associated with ethical acceptance, the use of spatial genomics and transcriptomics is expected to be highly regulated in the Middle East and Africa region. European governments are at the forefront of promoting spatial analysis with government-backed projects introducing new supportive technologies and the rising shift to precision medicine across the economies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Spatial Genomics & Transcriptomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spatial Genomics & Transcriptomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instruments
    • Software
  • Technology
    • Immunohistochemistry Screening
    • Spatial Genomics
      • Biochemical Techniques
      • Fluorescence in Situ Hybridization
      • Genome Perturbation Tools
      • Massively-Parallel Sequencing
      • Microscopy-Based Live DNA Imaging
    • Spatial Transcriptomics
      • In Situ Sequencing
      • Microtomy Sequencing
      • Sequencing-Based Methods
      • Transcriptome In-vivo Analysis
  • End-Use
    • Academic Institutes
    • Diagnostic Institutes
    • Pharmaceutical Manufacturer
    • Translational Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Spatial Genomics & Transcriptomics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spatial Genomics & Transcriptomics Market?
  3. What are the technology trends and regulatory frameworks in the Spatial Genomics & Transcriptomics Market?
  4. What is the market share of the leading vendors in the Spatial Genomics & Transcriptomics Market?
  5. Which modes and strategic moves are suitable for entering the Spatial Genomics & Transcriptomics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Spatial Genomics & Transcriptomics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
5.1.2. Restraints
5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
5.1.3. Opportunities
5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
5.1.3.2. Rising public and private funding for genomics & transcriptomics research
5.1.4. Challenges
5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Spatial Genomics & Transcriptomics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Software
7. Spatial Genomics & Transcriptomics Market, by Technology
7.1. Introduction
7.2. Immunohistochemistry Screening
7.3. Spatial Genomics
7.4.1. Biochemical Techniques
7.4.2. Fluorescence in Situ Hybridization
7.4.3. Genome Perturbation Tools
7.4.4. Massively-Parallel Sequencing
7.4.5. Microscopy-Based Live DNA Imaging
7.4. Spatial Transcriptomics
7.5.1. In Situ Sequencing
7.5.2. Microtomy Sequencing
7.5.3. Sequencing-Based Methods
7.5.4. Transcriptome In-vivo Analysis
8. Spatial Genomics & Transcriptomics Market, by End-Use
8.1. Introduction
8.2. Academic Institutes
8.3. Diagnostic Institutes
8.4. Pharmaceutical Manufacturer
8.5. Translational Research
9. Americas Spatial Genomics & Transcriptomics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Spatial Genomics & Transcriptomics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
12.3.1.2. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
12.3.1.3. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
12.3.1.4. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
12.3.2. New Product Launch & Enhancement
12.3.2.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
12.3.2.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
12.3.2.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
12.3.2.4. NanoString Launches New nCounter Pro Analysis System
12.3.3. Investment & Funding
12.3.3.1. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 10X Genomics, Inc.
13.1.2. Akoya Biosciences, Inc.
13.1.3. Arima Genomics, Inc.
13.1.4. AtlasXomics Inc.
13.1.5. Axcelead Drug Discovery Partners Inc.
13.1.6. BGI Australia
13.1.7. Bio-Techne Corporation
13.1.8. BioSpyder Technologies Inc.
13.1.9. Bruker Corporation
13.1.10. Bucher Biotec AG
13.1.11. CD Genomics
13.1.12. CeGaT GmbH
13.1.13. Dovetail Genomics, LLC
13.1.14. Easi-Genomics
13.1.15. Enzo Life Sciences, Inc.
13.1.16. Eurofins Genomics
13.1.17. Fulgent Genetics
13.1.18. Genomic Vision SA
13.1.19. Illumina, Inc.
13.1.20. Indivumed Group
13.1.21. Ionpath, Inc.
13.1.22. Lunaphore Technologies S.A.
13.1.23. Miltenyi Biotec
13.1.24. Nanostring Technologies, Inc.
13.1.25. Natera Inc.
13.1.26. Novogene Co, Ltd.
13.1.27. Oxford Nanopore Technologies PLC
13.1.28. PerkinElmer, Inc.
13.1.29. PT Pandu Biosains
13.1.30. Rarecyte, Inc
13.1.31. Rebus Biosystems, Inc.
13.1.32. Resolve Biosciences GmbH
13.1.33. S2 Genomics, Inc.
13.1.34. Seven Bridges Genomics
13.1.35. Single Cell Discoveries
13.1.36. Single Technologies AB
13.1.37. Singular Genomics System, Inc.
13.1.38. Spatial Genomics
13.1.39. Springer Nature
13.1.40. Standard BioTools Inc.
13.1.41. Tecan Group Ltd.
13.1.42. Ultivue, Inc.
13.1.43. Veracyte, Inc.
13.1.44. Veranome Biosystems, LLC
13.1.45. Vizgen Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
FIGURE 7. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 13. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOCHEMICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOME PERTURBATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MASSIVELY-PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPY-BASED LIVE DNA IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 20. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROTOMY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSCRIPTOME IN-VIVO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DIAGNOSTIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 48. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 49. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 75. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 76. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 80. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 81. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 91. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 121. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 137. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 163. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 166. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 167. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 186. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 187. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 191. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 192. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 238. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 239. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET LICENSE & PRICING

Companies Mentioned

  • 10X Genomics, Inc.
  • Akoya Biosciences, Inc.
  • Arima Genomics, Inc.
  • AtlasXomics Inc.
  • Axcelead Drug Discovery Partners Inc.
  • BGI Australia
  • Bio-Techne Corporation
  • BioSpyder Technologies Inc.
  • Bruker Corporation
  • Bucher Biotec AG
  • CD Genomics
  • CeGaT GmbH
  • Dovetail Genomics, LLC
  • Easi-Genomics
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • Fulgent Genetics
  • Genomic Vision SA
  • Illumina, Inc.
  • Indivumed Group
  • Ionpath, Inc.
  • Lunaphore Technologies S.A.
  • Miltenyi Biotec
  • Nanostring Technologies, Inc.
  • Natera Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • PT Pandu Biosains
  • Rarecyte, Inc
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Single Cell Discoveries
  • Single Technologies AB
  • Singular Genomics System, Inc.
  • Spatial Genomics
  • Springer Nature
  • Standard BioTools Inc.
  • Tecan Group Ltd.
  • Ultivue, Inc.
  • Veracyte, Inc.
  • Veranome Biosystems, LLC
  • Vizgen Corporation

Methodology

Loading
LOADING...

Table Information